Appendix 4E & 2024 Annual Report
| Stock | Enlitic Inc (ENL.ASX) |
|---|---|
| Release Time | 28 Feb 2025, 3:26 p.m. |
| Price Sensitive | Yes |
Appendix 4E & 2024 Annual Report
- Revenues up 129.4% to $1,078,860
- Loss down 2.0% to $15,237,895
- Acquired Laitek group of companies in October 2024
Enlitic, Inc. is a software development company using artificial intelligence to manage medical imaging data in radiology and licenses its products to healthcare providers and original equipment manufacturers. The company has built significantly on its foundations and is now well positioned to accelerate its position as a leader in healthcare medical imaging data standardisation, data anonymisation and data migration. In 2024, Enlitic released key components of Ensight 2.0, 18 months ahead of its development schedule. Ensight 2.0 deidentifies Protected Health Information in medical images and improves data quality, enabling healthcare providers to realise value from an increasing number of use cases and improves radiologist reporting workflows. The company also saw continued momentum in its sales progress during the year, signing up healthcare providers and OEM healthcare vendors and distributors to software licenses and vendor agreements, entering into 16 new agreements. Additionally, Enlitic completed the acquisition of the Laitek group of companies in October 2024, which has made the company a significant provider of tech-enabled healthcare medical imaging data migration and routing services.
Revenues from ordinary activities up 129.4% to $1,078,860 for the year ended 31 December 2024.
Enlitic is well positioned to accelerate its position as a leader in healthcare medical imaging data standardisation, data anonymisation and data migration through its continued focus on product development and sales progress.